您的購物車內沒有商品!
Searching for biotech stocks under $10 reveals several companies with strong analyst backing and significant upcoming catalysts. As of late 2025 and early 2026, the following stocks are frequently highlighted by financial experts for their growth potential: Top Rated Biotech Stocks Under $10 :
According to data from WallStreetZen , several lower-priced biotechs show favorable Price-to-Earnings (P/E) ratios compared to industry peers as of early 2026: BioCryst Pharmaceuticals AUPH Aurinia Pharmaceuticals TBPH Theravance Biopharma PBYI Puma Biotechnology
Recent Phase 1b study results for its Crohn's disease treatment showed a favorable safety profile with no serious adverse events. : best biotech stocks to buy under $10
: Noted for its inhaled therapy for pulmonary arterial hypertension and its recent pursuit of FDA pediatric approval.
: Highlighted for strengthening its global reach through strategic deals, such as the one with Kyowa Kirin. Searching for biotech stocks under $10 reveals several
Currently receiving an from analysts at Wolfe Research , with a price target of $7.
The company recently expanded its pipeline by acquiring DMX-200 for kidney disease. : Highlighted for strengthening its global reach through
It was also recognized as a top stock for day trading due to high relative volume. Value-Oriented Biotech Picks